Business Context and Reporting Period
Company: Oncolytics Biotech Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: November 17, 2009 (Reporting for November 2009)
Context: This filing serves to incorporate by reference the consent of the Independent Registered Public Accounting Firm into a previously filed Registration Statement on Form F-10 (File No. 333-151513). The filing does not contain operational updates or new financial statements for the current period.
Key Financial Metrics
The filing text does not provide current revenue, profit, cash flow, margins, debt, or liquidity figures for the reporting period. It references historical financial statements (balance sheets as of December 31, 2008 and 2007, and statements of loss and cash flows for the three-year period ended December 31, 2008) contained in the Annual Report on Form 20-F, but does not reproduce those specific numbers.
Material Changes
No material changes to financial position or operations are reported in this document. The filing is procedural, updating the registration statement with auditor consent.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. The primary content is the formal consent from the Chartered Accountants to the use of their audit report dated March 4, 2009.
Investor Verification Checklist
- Verify the status of the Registration Statement on Form F-10 (File No. 333-151513) referenced in the consent.
- Review the Annual Report on Form 20-F for the year ended December 31, 2008, to access the actual financial data (losses, cash flows, and balance sheet items) mentioned in the auditor's consent.
- Confirm the identity of the Independent Registered Public Accounting Firm providing the consent.